Why Attend
The average consumer spends $5 a day on skincare, whilst using up to 515 synthetic chemicals daily to eradicate dermalogical concerns - how can this be good for skin? Introducing the Skin Microbiome Congress.
Following the mainstream focus on the gut microbiome and its role in health and disease, researchers and industry experts are now turning their attention towards the emerging relationship between the skin microbiome and healthy skin. This has the potential to revolutionise the beauty and personal care industry.
View highlights from the inaugural Skin Microbiome Congress, May 30-31, 2018
Join 200+ industry experts from multinational pharmaceutical, beauty and personal care companies, along with the independent skincare brands and innovative biotechs who are advancing the field.
Discover the potential of prebiotic, probiotic and postbiotic products being developed to protect and promote a healthy microbiome and ultimately combat dermatological conditions from acne and eczema to dandruff and skin allergies. Take advantage of:
- Effective Networking - Pre-schedule private meetings with any individual or company onsite using the online meeting scheduler application
- Cutting Edge Research – Discover the latest advancement in therapeutic & cosmetic products containing live bacteria, bacterial extracts, or active ingredients to promote & protect the skins microbiome
- Consumer Trends - Understand how consumers trends towards natural, organic products and active beauty are shaping the evolution of products adapted to the skin microbiome
- Clinical Trials – Explore how to design an effective clinical trial & translate research into clinically & commercially viable therapeutics
- Competitive Edge – Determine how to differentiate your product line & seize this market opportunity, gaining market share with scientifically backed products
- Regulation – Understand the different paths to market & regulatory considerations necessary to launch a cosmetic or therapeutic product
With an increasing consumer trend towards natural products, what’s more natural than harnessing the bacteria on your skin? Don't miss your chance to understand the next generation of natural skincare products!
Sample of Industry Leaders & Innovators attending our Boston Summit
The Agenda
Simply fill in this form and we'll send you a PDF version of the agenda immediately. We need some information to know where to send the file and how to address our email to you.
We've received great feedback on other similar events...
3rd Annual European Microbiome Congress: The Next Big Thing in Microbiome...Skin
Beauty & Money Summit 2018
Download Agenda
Skincare Spotlight Selection Committee
Author:
Kimberly Capone
Kimberly Capone is a Research Fellow and Lead Microbiologist for Skin Microbiome Research with Johnson & Johnson Consumer Companies, Inc. in Skillman, NJ. She received her B.S. in Biology from Northeastern University in Boston, MA, proceeding to earn her Ph.D. in Microbiology and Immunology from Northwestern University in Chicago, IL. As a Research Fellow at Johnson & Johnson Consumer Companies, Inc., Dr. Capone directs investigations into the human skin microbiome in health and disease, particularly early in life and in individuals with sensitive or inflamed skin. In the course of her work, Dr. Capone has authored numerous peer-reviewed papers and has participated in national and international dermatology conferences.
Author:
Travis Whitfill
Travis Whitfill is an Associate Research Scientist in the Department of Pediatrics. His background began in molecular biology and biochemistry, after receiving scientific training at the MD Anderson Cancer Center and Duke University. He is the co-founder of several additional startup companies, including a Connecticut-based microbiome company, Azitra Inc. He brings strong background in entrepreneurship and business, and is also a partner in a venture capital fund, Bios Partners, bringing experience in public markets, drug development, and venture capital investments.
His research interests are in pediatric emergency medicine and health policy and to improve pediatric acute care across the United States.
Author:
David H. Crean
David H. Crean, Ph.D is a Managing Director at Objective Capital Partners where he leads the firms life science investment banking transactions. Dr. Crean has in excess of 20 years of life sciences R&D and corporate development transactional experience in the pharmaceutical industry where he was responsible for leading mergers, acquisitions, licensing and collaborations, and establishing corporate strategy. Davids transaction experience in the life sciences sector includes sell-side, buy-side, licensing and capital raising activities. He has supported company and client engagements in both U.S. domestic and foreign transactions including Japan, China and Europe.
Prior to joining Objective Capital Partners, Dr. Crean served over 20 years in specialty pharmaceuticals; namely at Allergan (NYSE:AGN) and Aqua Pharmaceuticals, a private equity-backed company, prior to being sold to Almirall, SA. (BME:ALM). Dr. Crean has led transaction execution in a wide range of specialty areas including aesthetic and therapeutic dermatology, OTC skin care, neurological disorders / CNS, pain, inflammation, ophthalmology, oncology and diagnostics/ detection. His corporate pharmaceutical experience spans research and development expertise in small molecules, biologics, prescription drugs, OTC products and medical devices.
Dr. Creans pharmaceutical and biotechnology leadership experience includes serving in key leadership roles in the development and/or growth of many commercial portfolios including: BOTOX, LUMIGAN, JUVEDERM, LATISSE, ACZONE, TAZORAC, MONODOX, FLUOROPLEX, XOLEGEL and VERDESO. Concurrent with Objective Capital, Dr. Crean serves as a strategic business advisor for several life science companies, is an active member on BIOCOMs Capital Development Committee and BIO International 2017 Partnering Committee and a contributing member on the Membership & Program Committees for the Association for Corporate Growth (ACG) in San Diego.
Dr. Crean holds a Masters of Business Administration Degree with a finance concentration from Pepperdine University School of Management. Additionally, he holds a Doctorate of Philosophy Degree in Biophysics and a Masters of Science Degree in Oncology from the State University of New York at Buffalo. Dr. Crean also earned a Bachelor of Science Degree in Biology from Canisius College.
Dr. Crean holds FINRA Series 79 and Series 63 licenses and is a Registered Representative of BA Securities LLC, Member FINRA SIPC.
Author:
Raymond Ip
Author:
Imke Meyer
Author:
Dr Phil Bolton
Phil obtained his Ph.D in organometallic chemistry from the University of Durham in 2000 and subsequently joined P&G where he worked on new technology development for the hair colourant category. Phil then joined RB in 2006 and has worked across a number of Innovation and Category R&D ROLES IN THE UK, Italy, Singapore and the US, becoming a director in 2010 and returning back to the UK based RB HQ in April 2015.
Phil currently leads the Outside Innovation team and has responsibility for delivering new and innovative solutions to the Health category pipelines. This can be anything from an ingredient in the product, through to products themselves, forging sustainable partnerships as well as being a strategic innovation partner for the senior category leadership within RB.
Author:
John Gannon, Ph.D.
Currently, John serves as the Microbiome Platform Technical Team Leader within DuPont’s Industrial Biosciences. He designed, initiated, and developed the technical infrastructure that serves as the research platform for Microbiome related initiatives and leads the Microbiome technical team for the DuPont Industrial Biosciences business. He has 27 years of experience with DuPont and has served as the lead scientist and/or technical leader for a variety of microbiology, microbial ecology, and environmental fate-related initiatives.
He was recruited by DuPont in 1991 to start up DuPont’s environmental fate competency for industrial chemicals. He became globally-recognized as a leading industrial expert in environmental sciences, which is based on his unique combination of expertises in biodegradation, microbial ecology, microbial physiology, environmental chemistry, and computational sciences. He has served on Science Advisory Boards, advisory groups, and expert panels for Environment Canada, U.S. EPA, Trent University, Rutgers Environmental & Occupational Safety & Health Institute, and currently with the NJ Department of Environmental Protection. Over the last 5 years, he has focused his work on microbiology related initiatives focused on further development of DuPont’s Microbiome Platform.
He received his Ph.D. in Microbiology from New York University and his Postdoc was in the laboratory of Dr. Martin Alexander at Cornell University.
Author:
Marie Cesbron
Marie Cesbron is a health&beauty leader with over two decades of hands-on experience transforming global brands such as Lancôme, Maybelline, Vichy Laboratories and building innovation capabilities within L’Oréal R&D as well as Walgreens Boots Alliance. She currently is Director of Innovation at Walgreens Boots Alliance’s consumer brand arm. Deeply in tune with changing consumer behaviours and macro-trends, she is passionate about the merge between wellness, health and beauty. She has worked and lived in Paris, New York and London. Marie holds an MS in Marketing from HEC Paris and a BS in Psychology from Paris Descartes University.
The Speakers
Jasmina Aganovic
Jasmina Aganovic is the President of Mother Dirt, a line of biome-friendly personal care products focused on restoring and maintaining the balance of the skin biome. The technology is based off research from AOBiome Therapeutics, a biotech company focused on transforming human health through products that restore Ammonia-Oxidizing Bacteria (AOB), which current hygiene practices have stripped from the modern microbiome. She is a cosmetics and consumer goods entrepreneur who received her degree in chemical and biological engineering from MIT. Her career path combined her technical background with roles at consumer brands like LVMH, Fresh, and Living Proof.
Dana Hosseini
A serial entrepreneur who has managed and co-founded a number of genomics-based companies including, ProdermIQ, Iceland Genomics and DiThera. Mr. Hosseini's skills in international medical device/diagnostic sales and marketing were developed at Abbott Laboratories, Ortho Clinical Diagnostics (Johnson & Johnson) and Sequenom, where he held executive and management positions in business development, and sales and marketing functions. He has 25+ years of extensive experience working with global biotech, pharmaceutical companies and healthcare providers. He received both his B.Sc. and MBA from the University of British Columbia.
Dr. Jay Tiesman
Dr. Jay Tiesman is a Principal Scientist in the Global Biotechnology Division of The Procter & Gamble Company in Cincinnati, Ohio, USA. He is the Genomics Group Leader and a Corporate Technology Entrepreneur – charged with helping to identify novel biotechnology innovations worldwide to address key needs for P&G. Since joining P&G in 1993, he has been actively involved in developing genomics capabilities within the Company. He has been particularly interested in the use of genomics to gain insight into epithelial cell biology.
Before joining P&G, he completed postdoctoral training in the laboratory of Dr. Charlie Hart at ZymoGenetics, Inc. in Seattle, Washington. At ZymoGenetics, he pursued research in the field of growth factor signal transduction associated with wound healing and tissue remodeling.
He obtained his Ph.D. in Pathology from the University of Nebraska Medical Center in Omaha, Nebraska. In Omaha, he worked in the Laboratory of Dr. Angie Rizzino at the Eppley Cancer Institute, delineating the roles and impact of growth factors on embryonic development.
Before joining Dr. Rizzino, he obtained Bachelor degrees in Philosophy and Biology at Creighton University in Omaha. Dr. Tiesman was an early adopter of microarray technology, having worked in the field since 1997. He is an acknowledged microarray expert and has published over 35 articles, two of which have earned “Publication of the Year” honors.
He also speaks extensively at international meetings on the topic of microarray experimental design and is listed on over 85 presentations. He collaborates extensively with scientists in academia and the biotechnology industry and is a member of several academic/governmental/industrial organizations, including the Association of Biomedical Resource Facilities Microarray Research Group (ABRF-MARG), the Association of Molecular Pathology (AMP), and the Society for Investigative Dermatology (SID); as well as the Scientific Advisory Board of NuGEN Technologies, Inc.
Allison Krebs Bensch
Allison Krebs-Bensch, a graduate of Vanderbilt University, has been intrinsically involved in her family’s pharmaceutical business, US Pharmaceutical Corporation, since graduating. Rolling up her sleeves, Allison dove into learning every aspect of the business from Sales to R & D, before eventually taking over the responsibilities of CEO.
Allison’s accomplishments include being listed as an inventor on patents for Improved Toleration of Iron Supplement Compositions. Additionally, she has developed, progressive & pending, patented formulations utilizing new probiotic strains for various applications of use. Most recently, she has co-founded and is CEO of a start-up probiotic skin care company, BeBe and Bella. This company specializes in delivering probiotics and their fermented filtrates, both orally and topically, for improved natural beauty. As co-founder, Allison has been invited to be a Speaker at several symposiums related to the science behind probiotics.
Emma Taylor
Dr. Emma Taylor the CEO and co-founder of Naked Biome, a microbiome therapeutics company, focused in acne She is a UCLA-trained and board certified Dermatologist and Dermatopathologist, and former assistant professor of Dermatology and Dermatopathology at UCLA, where she c0-founded Naked Biome. She is also an inventor of 2 published patents, has published in notable journals such as Nature and the Journal of the American Academy of Dermatology, and is the author on more than 40 book chapters.
Richard Andrews
Mr. Andrews has spent most of his career as a C level executive leading operations, finance, and commercial and clinical development for biotechnology firms focused on new products that address inflammatory disease. Mr. Andrews has been instrumental in translating research and academic discoveries into product development and advanced clinical programs, building alliances and partnerships and organizing operational teams. Financing processes led by Mr. Andrews have secured over $130M in equity funding for new ventures. His work has been primarily focused on skin disease, pneumonia, infant hypoxic ischemia and kidney failure. Early in his career, Mr. Andrews led the commercialization of several natural cell systems to prevent disease on fruits and vegetables and launched several DNA diagnostic tests for periodontal disease. Mr. Andrews received graduate degrees in physical biochemistry (MS), and technology management (SM) from Purdue University, and the Massachusetts Institute of Technology, respectively. He also has an undergraduate degree in Chemistry (BS) from Hobart College.
Marie Drago
Marie Drago is a French Doctor in Pharmacy and a member of the French Society of Cosmetic Science, with over 15 years’ experience working for successful and innovative skincare brands. After discovering how a prebiotic and probiotic diet could improve the symptoms of the gluten intolerance that had been plaguing her life for years, Marie got a Eureka moment: What if we applied the same science to skin?
Marie’s thesis on the microbiome and the enormous benefits of harnessing helpful bacteria gave her the vision and the know-how to create Gallinée’s formulations. Thanks to her pharmacy background and her beauty experience, Marie designed formulas like no other, and patented the triple biotic complex that you can now find in Gallinée’s products.
Defne Saral
Currently Defne is the business leader for the commercial and technology offering of DuPont Industrial Biosciences (IB) to the personal care and cosmetics industry. She is part of the commercial industry leadership team, has responsibility for profit & loss and leads the global personal care team. She has 22 years of experience in global companies across a variety of industries.
Defne joined DuPont in 2005 after her MBA and has held commercial roles in marketing, sales, product management and business development. She has worked in specialty materials and ingredients for the fire fighting industry, textiles, paints & coatings, automotive, construction and retail. Prior to personal care, she was leading the food enzymes unit of IB developing offerings to improve freshness, optimize production, add texture, ensure quality consistency and reduce waste, water and energy consumption.
Prior to DuPont, she worked for 7 years at Philip Morris International, starting in Operations for Eastern Europe integrating acquisitions, moving to M&A, was Marlboro brand manager for Switzerland and head of strategic planning for the worldwide duty free unit.
Defne holds an MBA from IMD, Switzerland and a Bachelor in Systems Science Engineering from the University of Pennsylvania, USA. She was born in the US, is of Turkish origin, and is a Swiss citizen.
David Tyrrell
David’s experience in skincare has spanned over 15 years. During his tenure at Kimberly-Clark he held positions in Corporate Research, New Product Development and Technology Scouting & Alliance Management. He has been active in identifying a variety of consumer and medical device technologies and products for in-licensing and led international research efforts in the biological characterization of naturally sourced skincare ingredients. David has a BS in Chemistry and a PhD in Biochemistry.
Qun Wang
Ronie Schmelz
Travis Whitfill
Travis Whitfill is an Associate Research Scientist in the Department of Pediatrics. His background began in molecular biology and biochemistry, after receiving scientific training at the MD Anderson Cancer Center and Duke University. He is the co-founder of several additional startup companies, including a Connecticut-based microbiome company, Azitra Inc. He brings strong background in entrepreneurship and business, and is also a partner in a venture capital fund, Bios Partners, bringing experience in public markets, drug development, and venture capital investments.
His research interests are in pediatric emergency medicine and health policy and to improve pediatric acute care across the United States.
Julia French
Joy Chen
Stephen Roman
Elsa Jungman
Dr. Elsa Jungman has a Ph.D. in Skin Delivery and began her career working in Research and Development for L’Oreal in Paris. In 2015 she moved to San Francisco and has worked with several biotech and skincare companies such as AOBiome. She is an expert for the Clean Beauty Council at Credo Beauty and mentors/consults with local small companies. Today, she is the founder and CEO of ELSI Skin Health, a science-backed and clean skincare startup.
Dr Phil Bolton
Phil obtained his Ph.D in organometallic chemistry from the University of Durham in 2000 and subsequently joined P&G where he worked on new technology development for the hair colourant category. Phil then joined RB in 2006 and has worked across a number of Innovation and Category R&D ROLES IN THE UK, Italy, Singapore and the US, becoming a director in 2010 and returning back to the UK based RB HQ in April 2015.
Phil currently leads the Outside Innovation team and has responsibility for delivering new and innovative solutions to the Health category pipelines. This can be anything from an ingredient in the product, through to products themselves, forging sustainable partnerships as well as being a strategic innovation partner for the senior category leadership within RB.
Imke Meyer
Raymond Ip
Eric Huang, PhD
Kit Wallen-Russell
With a Masters Degree in Geophysics from University College London (UCL), twice published scientific author, and JooMo Co-Founder Kit published a peer-reviewed paper in 2017 that describes the first ever mechanism to determine whether skin is healthy or not. As director of the Pavane Research Centre (the R&D arm behind all ground-breaking JooMo technology), he discovered that the ONLY indicator of healthy skin was high microbial biodiversity, not the presence/lack of particular microbes. The immense power of his discovery meant that, for the first time, it was possible to determine whether everyday cosmetics really are the primary cause of the skin allergy epidemic that’s raging across the western world. To do so, Kit formed a partnership with top European institution, The Medical University of Graz, to test everyday cosmetics, including JooMo, for their effect on skin health. The extremely intriguing results from the seminal study will have been published by Kit at the time of the event. Both Kit and Nick aim to dispel the myths and ill-education surrounding Probiotics within the industry, and distance JooMo from the Pro-/Pre- Biotics label. JooMo is NOT a probiotic.
John Gannon, Ph.D.
Currently, John serves as the Microbiome Platform Technical Team Leader within DuPont’s Industrial Biosciences. He designed, initiated, and developed the technical infrastructure that serves as the research platform for Microbiome related initiatives and leads the Microbiome technical team for the DuPont Industrial Biosciences business. He has 27 years of experience with DuPont and has served as the lead scientist and/or technical leader for a variety of microbiology, microbial ecology, and environmental fate-related initiatives.
He was recruited by DuPont in 1991 to start up DuPont’s environmental fate competency for industrial chemicals. He became globally-recognized as a leading industrial expert in environmental sciences, which is based on his unique combination of expertises in biodegradation, microbial ecology, microbial physiology, environmental chemistry, and computational sciences. He has served on Science Advisory Boards, advisory groups, and expert panels for Environment Canada, U.S. EPA, Trent University, Rutgers Environmental & Occupational Safety & Health Institute, and currently with the NJ Department of Environmental Protection. Over the last 5 years, he has focused his work on microbiology related initiatives focused on further development of DuPont’s Microbiome Platform.
He received his Ph.D. in Microbiology from New York University and his Postdoc was in the laboratory of Dr. Martin Alexander at Cornell University.
Richard LaDuca
Currently Rich is part of the technology leadership team within DuPont’s Industrial Biosciences (IB) Business. He works within a portfolio management team and has direct responsibilities for resource allocation for projects within IB as well as with our cross pillar partner programs. He has 34 years of experience in the development of bio-based products and new business initiatives.
Rich started his career in industrial biotechnology in 1984 as a research scientist when he joined Kodak’s Research Labs working with an interdisciplinary team to develop microbial cell factories to produce biochemicals. He has worked on programs to produce lysine, threonine, biotin, tryptophan, indigo and ascorbic acid. He was part of the Kodak team that helped form Genencor International where his efforts transitioned from research to business development. He has had an active role in establishing partnering relationships in the biochemicals and biomaterials science areas with companies such as Archer Daniels Midland (ADM), Eastman Chemical Co. (Ascorbic Acid) , Dow Corning (Silicon Biotechnology Platform) and The Goodyear Tire & Rubber Company (BioIsoprene).
Rich holds a Ph.D. in Microbial Cell Physiology from The University of Buffalo (Roswell Park Mem. Inst.) and completed a Post doctoral Fellowship Program in Biochemistry at the University of Rochester.
Suneer Jain
I am a driven, educated, and enthusiastic scientist that believes in the healing of molecular medicine. Over the past several years, my career has afforded me the opportunity to work with some of the nation’s most foremost experts in the fields of molecular medicine, sequencing, and cell technology. I have worked on a number of exciting and innovative projects and was part of the team that established the Illumina Clinical Services Laboratory and worked to successfully sequence the first whole human genome in a CLIA-certified, CAP-accredited laboratory.
Céline Blanchard
After finalizing her study of biology, Céline received her M.Sc. in Cosmetic Natural Active Ingredients from ISIPCA in Versailles, France.
She held positions in New Product Development, Scientific Communication and Innovation Management at several raw materials’ suppliers and currently, Céline is part of the R&D department within BIOEUROPE as Cutaneous Biology Research Engineer.
Michael Hoptroff
Michael Hoptroff, has over 20 years’ experience working on the microbiology of Beauty and personal Care. His research has spanned the development and formulation of topical antimicrobials to the characterisation and modulation of the microbiomes of skin, scalp and the oral mucosa. Having recently returned from four years secondment in China Michael is currently leading the Unilever UK Personal Care microbiology team.
Greg McParland
Wayne Willis
Sponsors
Associate Partners
Reckitt Benckiser
Website: http://www.rb.com
Who we are
We’re 40,000+ entrepreneurs, all inspired by a vision of a world where people are healthier and live better. At the heart of our rapidly growing consumer health business is a passionate desire to help people feel better. We invest in research and development to find ways for people to look after themselves, their families and homes.
Why we’re here
We believe there's a better way to do business – we like to call it 'betterbusiness'. Socially, environmentally and financially, we act responsibly and sustainably. We believe passionately in doing things the right way, and we believe the better way helps us deliver high quality products that touch consumers each and every day. Health is no longer just the absence of illness, it’s being able to lead a fitter and happier life. Our responsibility is to help people achieve this, while making the right kind of social and environmental impact. That’s what we call betterbusiness.
DuPont
Website: http://www.dupont.com/
DUPONT INDUSTRIAL BIOSCIENCES
DuPont Industrial Biosciences, a business unit of DowDuPont Specialty Products Division, works with customers across a wide range of industries to make products and industrial processes more efficient and sustainable. Through a unique combination biotechnology, chemistry and material science capabilities, we advance market-driven, biobased solutions to meet the needs of a growing population, while protecting our environment for future generations. For updates about how DuPont Industrial Biosciences is helping customers deliver cost-effective products with superior performance and sustainability, follow @DuPontBiobased on Twitter or visit our website at biosciences.dupont.com.
DOWDUPONT SPECIALITY PRODUCTS DIVISION
DowDuPont Specialty Products, a division of DowDuPont (NYSE: DWDP), is a global innovation leader with highly differentiated materials, ingredients and capabilities that help transform industries and everyday life. DowDuPont Specialty Products includes five technology-driven businesses: Electronic Technologies, Industrial Biosciences, Nutrition & Health, Protective Solutions and Sustainable Solutions. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver real-world products and smart solutions across multiple high-value markets. DowDuPont intends to separate the Specialty Products division into an independent, publicly traded company.
www.dow-dupont.com.
Symrise
Website: http://www.symrise.com
Symrise is a global supplier of fragrances, flavorings, cosmetic active ingredients and raw materials, as well as functional ingredients. Its clients include manufacturers of perfumes, cosmetics, food and beverages, the pharmaceutical industry and producers of nutritional supplements and pet food.
Its sales of approximately € 3 billion in the 2017 fiscal year make Symrise a leading global provider in the flavors and fragrances market. Headquartered in Holzminden, Germany, the Group is represented in more than 90 locations worldwide.
COSMETIC INGREDIENTS focuses on high-quality ingredients, such as active skin and hair care ingredients, preservatives, botanical extracts, functional products, UV filters and colors.
Phytopia
Website: https://www.phytopiaroma.com/
CHANGE STARTS WITH ME.
Mahatma Gandhi once said, “Be the change you want to see in the world.” At Phytopia, we believe just by becoming a better version of yourself, the world around you begins to evolve positively.
Every day we deal with problems, small or large, and there are always new challenges to overcome. Oftentimes we hold the key to our own problems and sometimes we just need to clear our minds to discover that key. Over 15 years of experience, we believe aromatherapy has the power to help you find the answers within.
A firm believer in this concept, founder and certified aromatherapist Joan and her team have been traveling around the world to source only the finest plants. With the best natural ingredients, she was able to team up with the top distillation scientists in Asia to create the famous Phytopia therapeutic-grade remedies.
Making changes is a journey. Let us be there for you every step of the way, 1% better each time.
DSM
Website: https://www.dsm.com/personal-care/en_US/home.html
DSM in Personal Care & Aroma provides solutions for customers in the personal care, home care and fine fragrance markets. Its extensive portfolio includes aroma ingredients, vitamins and natural bioactives, as well as UV filters, peptides and polymers. With its competence & expertise in science, formulations, and applications it is well placed to deliver on diverse consumer beauty and health needs, especially in the context of aging populations and increasing ethnic & cultural requirements. The business also addresses the public health issue of globally rising skin cancer rates, providing innovative sun care solutions that extend beyond UV into the blue light range, and creating and creating awareness of the need to use sun protection daily.
Event Partner
Solabia
Website: http://www.solabia.com
Solabia Group is present in the cosmetics, pharmacy, nutrition, biotechnology and microbiological diagnosis sectors, the Solabia Group, with its six production units, has complementary expertise that enables it to offer an extensive range of active principles and ingredients used throughout the world by the cosmetics, pharmaceutical and food industries.
Our research and development centres group together more than thirty international calibre researchers whose original expertise – driver of innovation – enables us to completely master the techniques of biocatalysis, enzymatic synthesis, fermentation and plant extraction. This complementary expertise enables us to create innovative products as well as partnerships with both our customers and internationally renowned research organisations.
Eagle Genomics
Website: http://www.eaglegenomics.com
Eagle Genomics innovates at the intersection of biology, data science and bioinformatics to enable scientific decision making and to drive scientific discovery in the fields of microbiomics and human genomics.
Eagle Genomics knowledge discovery platform, e[automateddataascientist], transforms data into actionable insights that drive scientific decision making. The insight gained enables quick assessment of product potential, accelerates market entry and mitigates risk. Customers use our platform, powered by life sciences data, to prove the viability, efficacy and safety of products.
Media Partners
Cosmetics & Toiletries
Website: http://www.cosmeticsandtoiletries.com/
Cosmetics & Toiletries is the definitive resource delivering in-depth, peer-reviewed technical content within the context of current market trends. It empowers R&D professionals to imagine and invent cosmetics and personal care products with targeted technical coverage of relevant biology, chemistry & formulating techniques as well as reviewing product safety, regulatory issues and efficacy testing for today and tomorrow.
Dermatology Times
Website: http://dermatologytimes.modernmedicine.com/
Dermatology Times is a weekly newsmagazine and leading information source for dermatologists, offering credible, relevant and timely reporting on the latest trends in the specialty.
Our print and digital editions, our web site and our weekly e-newsletter provide more than just factual coverage of cutting-edge research and current trends; they provide the context for practical application in day-to-day practice. We keep dermatologists at the forefront of the latest developments in their field.
Our qualified circulation reaches nearly 13,000 U.S.-based dermatologists, dermatologic surgeons, dermatologic osteopaths, dermatologic residents and other allied healthcare professionals.
Global Cosmetics News
Website: https://globalcosmeticsnews.com/
Global Cosmetics News is a digital publisher of the latest global business information for professionals working in the cosmetics industry.
We cover daily news relating to all aspects of the cosmetics industry, from raw materials and packaging design to manufacturing processes and product launches. We examine environmental issues and technological developments, monitor marketing campaigns and retail distribution, and report on mergers and acquisition, trading reports and regulatory updates. We source stories from across the world to provide the most comprehensive digital summary of the global supply chain.
Subscribe here to receive a summary of the day's top stories.
Cosmetic Business
Website: https://www.hpcimedia.com/Cosmetics-Business/
Cosmetics Business is the leading online platform for the professional beauty, personal care and toiletries industry with daily breaking news for products, manufacturing, ingredients, packaging, formulation, jobs, events and company information.
Euromonitor
Website: https://blog.euromonitor.com/tag/alcoholic-drinks/
Euromonitor International is a global market research company providing strategic intelligence on industries, companies, economies and consumers around the world. Comprehensive international coverage and insights across consumer goods, business-to-business and service industries make our research an essential resource for businesses of all sizes. Euromonitor International acts as a trusted partner, providing actionable solutions to support decisions on how, where and when to grow your business.
Pharma Journalist
Website: http://www.pharmajournalist.com
Pharma Journalist is a leading international B2B magazine providing the global information and the recent updates in the Pharmaceutical Industry.
Our editorial staff works dedicatedly to provide latest information of Pharmaceutical Industry in the form of articles, news, trends, analysis, market report, press releases, whitepapers, case studies, etc. which helps Industry professionals and decision makers to stay on the top of this fast-paced industry.
Various Online marketing services and promotional activities through Pharma Journalist helps companies and organizations to reach their target audience and create brand awareness.
Chemical Search International
Website: https://www.chemicalsearch.co.uk/
Chemical Search International specialises exclusively in executive search, talent acquisition and professional career development services for the global chemicals and related sectors such as polymers, materials, natural resources and biosciences. We also own ChemExecSM | Executive Network, an exclusive online professional network dedicated to these same industries and which offers faster, simpler professional networking just when you need it. We have offices in London, New York and Singapore. Please contact us to discuss your company’s recruitment needs or to discuss your own personal career.
ChemExec
Website: https://www.chemicalsearch.co.uk/club/
Chemical Search International specialises exclusively in executive search, talent acquisition and professional career development services for the global chemicals and related sectors such as polymers, materials, natural resources and biosciences. We also own ChemExecSM | Executive Network, an exclusive online professional network dedicated to these same industries and which offers faster, simpler professional networking just when you need it. We have offices in London, New York and Singapore. Please contact us to discuss your company’s recruitment needs or to discuss your own personal career.
HAPPI
Website: https://www.happi.com/
HAPPI is the leading media outlet in the global personal care and household product market. Celebrating 50 years of global coverage in 2013, Happi provides in-depth analysis of this $530 billion market for our 16,500 subscribers around the world.
In recent years, we’ve added features on a variety of subjects, expanded coverage in fast-growing markets in Asia and Latin America, and even added new events such as our Anti-Aging Conference & Tabletop Exhibition. That’s why after 50 years, Happi remains the No. 1 vehicle to promote your company’s products and services.
Global Cosmetic Industry
Website: http://www.gcimagazine.com/
Global Cosmetic Industry magazine is the preferred resource for US-based marketers, brand managers, manufacturers and executives in the beauty industry.
ChemLinked | Cosmetic
Website: https://cosmetic.chemlinked.com/
ChemLinked Cosmetic Portal was created to provide cosmetic regulatory information for China and the rest of the Asia Pacific region to meet the growing demand for clear and concise regulatory advice and market intelligence.
Mintel
Website: http://www.mintel.com
Mintel is the world’s leading market intelligence agency, delivering in-depth research and insight into the beauty industry. From the latest trends and innovations to current consumer behavior and forecasts, Mintel's team of expert analysts combine high-quality data and rich marketplace knowledge to inform 3,000 beauty brands globally. With 13 offices across five continents, we have forged our unique reputation as a world-renowned business brand. For more information on Mintel, please visit www.mintel.com.
Who Will Be There
Venue
Hotel Kabuki, 625 Post St, San Francisco, CA 94115, USA
The 2nd Skin Microbiome Congress wil be taking place in Hotel Kabuki, Japantown, San Francisco.
Hotel Kabuki is one of the few boutique hotels just steps from Pacific Heights’ famed Fillmore District, and provides easy access to some of San Francisco’s most exciting dining, shops, and sights, including Union Square, the Golden Gate Bridge, and Lombard Street.
Bedroom rate: $319 per night + Tax
Book now:
W: Book online
T: 415-614-5423
We have only 20 rooms available at this special rate, please quote KISACO RESEARCH to secure yours.
Conference Packages
Sending Your Team? Group Discounts Available!
Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates
Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off
If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920
Become a Sponsor
Kisaco Research provides the much-needed platform on which industry executives can network, connect and learn from each other as well as meet potential industry partners.
Far from the typical ‘meet-and-greet’ exhibition experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event with a focus on the benefits of your product and brand, rather than just a name on an exhibition list.
With our extensive marketing experience and strategy, your partnership with Kisaco Research will grant you a sponsorship package that is an extension and enhancement of your current marketing and branding efforts. We value your ROI and will work with you directly on your specific goals and targets – that’s why we take special care in finding the most relevant end-users to attend, so that your financial and resource investment is smartly allocated.
Find out more by calling us at +44 (0)20 3696 2920 or email us at [email protected].
About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.
